(ALKS:Consolidated Issue Listed on NASDAQ Global Select )
Michael J. Landine
Senior Vice President of Corporate Development, Alkermes plc
|Age||Total Calculated Compensation||This person is connected to 12 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Mr. Michael J. Landine, also known as Mike, Founded Genomics Collaborative, Inc. Mr. Landine has been the Senior Vice President of Corporate Development of Alkermes plc (alternate name: Alkermes, Inc) since May 22, 2007. He serves as an Advisor of Walker Magnetics Group. He served as Vice President of Corporate Development of Alkermes, Inc. from March 1999 to May 22, 2007. From March 1988 to June 1998, Mr. Landine served as Chief Financial Officer and Treasurer of Alkermes, ...
Connaught HousePhone: 353 1 772 8000
Dublin, Co. Dublin 4
Board Members Memberships*
Founder and Director
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Former Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|David M. Stack||Chairman, Chief Executive Officer and President|
Pacira Pharmaceuticals, Inc.
|Thomas W. D'Alonzo Esq., J.D.||Chairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee|
Salix Pharmaceuticals Ltd.
|Arun Sawhney B.Com., P.G.D.B.M.||Chief Executive Officer, Managing Director, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee, Member of Quality & Integrity Committee, Member of Science Committee and Member of Corporate Social Responsibility Committee|
Ranbaxy Laboratories Ltd.
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|Alessandro E. Della Chà LL.M||Chief Executive Officer and Director|
Cosmo Pharmaceuticals S.p.A.
|--||Compensation as of Fiscal Year 2013.|